Seikagaku Corporation (TYO:4548)
Japan · Delayed Price · Currency is JPY 635.00
-5.00 (-0.78%)
Aug 8, 2025, 3:30 PM JST
Oncternal Therapeutics Revenue
Seikagaku had revenue of 8.73B JPY in the quarter ending June 30, 2025, a decrease of -12.88%. This brings the company's revenue in the last twelve months to 38.08B, up 4.13% year-over-year. In the fiscal year ending March 31, 2025, Seikagaku had annual revenue of 39.37B with 8.73% growth.
Revenue (ttm)
38.08B
Revenue Growth
+4.13%
P/S Ratio
0.91
Revenue / Employee
35.43M
Employees
1,075
Market Cap
34.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 39.37B | 3.16B | 8.73% |
| Mar 31, 2024 | 36.21B | 2.76B | 8.24% |
| Mar 31, 2023 | 33.46B | -1.40B | -4.00% |
| Mar 31, 2022 | 34.85B | 7.19B | 25.99% |
| Mar 31, 2021 | 27.66B | -980.00M | -3.42% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |